The Institute serves as a catalyst for global collaboration,
working with partners across the University of North Carolina and around the world.
Leading the response to COVID-19
At the onset of the pandemic, Institute for Global Health and Infectious Diseases researchers sprang into action, advising and partnering with the NIH, WHO and others on a coordinated response. By August 2020, Institute clinicians and researchers were engaged in 52 research projects including national vaccine and treatment trials. Watch the video at left to learn more.
Cindy Gay, MD, on leading COVID-19 vaccine trial; Ron Falk, MD, on participating
Michelle Floris-Moore, MD, MS, talks about impact of COVID-19 on African Americans
Michael Herce, MD, MPH, MSc: ¿Por qué participar en un esayo clinico?
Big Tent, One Team:
How a multidisciplinary research partnership built to fight HIV, Ebola, and other infectious diseases turned its people, expertise, and experience to fight COVID-19
In his March 23, 2021 story in UNC’s The Well, writer Scott Jared takes a deep look at the history and accomplishments of the Institute and Division of Infectious Diseases, especially how Institute Director Myron Cohen and ID Chief Joe Eron have cultivated a Big Tent way of thinking in which professionals of varying expertise work in synch with each other. The Big Tent philosophy “has no silos,” Cohen says. “We’re all working together on problems, and we all work together very successfully.”
Read story
2018-2020 Impact Report:
Pandemic highlights Institute’s critical role
Our abbreviated report includes updates from the Institute’s global sites, stats on the breadth and impact of our work, and a look at the COVID-19 research that our faculty launched in the spring of 2020 in reaction to the pandemic.
Download impact report
Now More Than Ever, Global is Local
Latest Institute news
-
NIH grant expands capacity to train emerging cancer researchers in Malawi
A five-year training grant from the National Institutes of Health’s National Cancer Institute expands the capacity of UNC’s Institute for Global Health & Infectious Diseases and Lineberger Comprehensive Cancer Center to train the next generation of cancer researchers in Malawi, Africa. The Malawi Cancer Outcomes Research Program, or M-CORP, includes funding for advanced degree … Continued
-
Hobbs and Duncan win $3.9M NIAID grant to study a meningitis vaccine’s effect on gonorrhea
The NIH’s National Institute of Allergy and Infectious Diseases has awarded UNC’s Marcia Hobbs and Alex Duncan a five-year, $3.9 million grant to study how a vaccine recently developed to prevent life-threatening infections caused by group B Neisseria meningitidis, the MenB vaccine, may also protect people from infection with Neisseria gonorrhoeae, a sexually transmitted bacterial … Continued
-
Study from DRC shows mother-infant HBV treatment, prevention feasible
Hepatitis B virus (HBV) remains endemic throughout sub-Saharan Africa despite the widespread availability of effective childhood vaccines. In the Democratic Republic of the Congo, HBV treatment and birth-dose vaccination programs are not established. UNC School of Medicine researchers led a study to evaluate the feasibility and acceptability of HBV testing and treatment of pregnant women, … Continued